Increase in 20–50 Hz (gamma frequencies) power spectrum and synchronization after chronic vagal nerve stimulation by Marrosu, Francesco et al.
DTD 5 ARTICLE IN PRESS
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
5758
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97EC
TE
D P
RO
OF
Increase in 20–50 Hz (gamma frequencies) power spectrum
and synchronization after chronic vagal nerve stimulation
F. Marrosua,*, F. Santonib, M. Puligheddua, L. Barberinia, A. Malecia,
F. Ennasa, M. Masciaa, G. Zanettib, A. Tuveria, G. Biggioc
aDipartimento di Scienze Neurologiche e Cardiovascolari, Policlinico Universitario, Universita` di Cagliari, SS 554, Bivio Sestu, 09042 Monserrato, Italy
bCRS4 Parco Scientifico e Tecnologico, POLARIS, Edificio 1, 09010 PULA (CA), Italy
cBiologia Sperimentale and CNR Sezione di Neuropsicofarmacologia, Universita` di Cagliari, SS 554, Bivio Sestu, 09042 Monserrato, Italy
Accepted 15 June 2005
Abstract
Objective: Though vagus nerve stimulation (VNS) is an important option in pharmacoresistant epilepsy, its mechanism of action remains
unclear. The observation that VNS desynchronised the EEG activity in animals suggested that this mechanism could be involved in VNS
antiepileptic effects in humans. Indeed VNS decreases spiking bursts, whereas its effects on the EEG background remain uncertain. The
objective of the present study is to investigate how VNS affects local and inter regional syncronization in different frequencies in
pharmacoresistent partial epilepsy.
Methods: Digital recordings acquired in 11 epileptic subjects 1 year and 1 week before VNS surgery were compared with that obtained
1 month and 1 year after VNS activation. Power spectrum and synchronization were then analyzed and compared with an epileptic group of
10 patients treated with AEDs only and with 9 non-epileptic patients.
Results: VNS decreases the synchronization of theta frequencies (P!0.01), whereas it increases gamma power spectrum and
synchronization (!0.001 and 0.01, respectively).
Conclusions: The reduction of theta frequencies and the increase in power spectrum and synchronization of gamma bands can be related to
VNS anticonvulsant mechanism. In addition, gamma modulation could also play a seizure-independent role in improving attentional
performances.
Significance: These results suggest that some antiepileptic mechanisms affected by VNS can be modulated by or be the reflection of EEG
changes.
q 2005 Published by Elsevier Ireland Ltd. on behalf of International Federation of Clinical Neurophysiology.
Keywords: Vagus nerve stimulation (VNS); Partial epilepsy; Digital EEG; Power spectrum frequency analysis; Intra–inter hemispheric synchronization
analysis; Gamma activity98
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RR1. Introduction
The use of long-term vagus nerve stimulation (VNS)
with intermittent electrical current was introduced for the
treatment of refractory epilepsy first in adults (Binnie, 2000;
Handforth et al., 1988; Labar et al., 1998; Morris and
Mueller, 1999; Salinsky, 1995) and subsequently in childrenUN
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110(Hornig et al., 1997; Patwardhan et al., 2000) and in older
individuals (Sirven et al., 2000). VNS reduces seizure
frequency by 50% in 30–40% of patients with severe
epilepsy (Ben-Menachem, 2002) and represents the only
non-pharmacological, non-surgical option for epilepsy
treatment (Binnie, 2000). The mechanism of the therapeutic
action of VNS remains unclear, however. Although its
efficacy has been suggested to result from complex
interactions of biochemical and electrical events (Beckstead
and Norgren, 1979; Kalia and Sullivan, 1982; Rutecki,
1990), few studies have examined the effects of VNS on
the EEG.Clinical Neurophysiology xx (xxxx) 1–11www.elsevier.com/locate/clinphational Federation of Clinical Neurophysiology. 111
112
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Early investigations showed that VNS at a frequency of
24–50 Hz induced rapid desynchronized activity in the
orbitofrontal cortex and cerebellum both in intact and in
‘encephale isole`’ cats (Bremer and Bonnet, 1951; Zanchetti
et al., 1952). Further studies found that vagal stimulation
at 30 Hz induced EEG desynchronization in cats (Magnes
et al., 1961) in a manner dependent on the histological
composition of the nerve fibers receiving the electrode
impulses. This effect is similar to that observed after
electrical stimulation of peripheral nerves (Pompeiano and
Swett, 1962). The pattern and target of stimulation are
important determinants of the effect observed, however,
given that desynchronization results from high-frequency
stimulation of fibers with a low level of myelination,
whereas synchronization occurs in response to low-
frequency stimulation of highly myelinated fibers (Chase
et al., 1967).
These experimental observations spurred several studies
that attempted to elucidate whether VNS induces similar
bioelectrical effects in humans. The first such study failed to
demonstrate substantial differences in recordings obtained
during wakefulness, sleep, or anaesthesia in epileptic
individuals examined before and after VNS activation
(Hammond et al., 1993). Another study detected a stable
rate of interictal spiking activity after the delivery of trains
of electrical impulses by VNS (Salinsky and Burchiel,
1993). However, more recent studies of the effects of
chronic VNS with long-term EEG monitoring have revealed
a progressive reduction in the frequency and duration of
sharp waves as well as a substantial decrease in interictal
spiking (Koo, 2002; Kuba et al., 2002)
These studies thus suggest that VNS modifies interictal
activity, although it has remained unclear whether
modification of the EEG pattern by long-term VNS plays
a role in the observed therapeutic action. In particular, it
remains scarcely investigated whether VNS modulates the
spectrum of EEG frequency and if such activity can be
related with variations of spiking and seizure episodes.
In addition, it is of interest to investigate possible relations
between the inter and intrahemisferic synchronization of
the EEG frequency bands, by assessing the coherences of
the EEG signals over the recording areas. As the procedure
of ‘generalized synchronization’ (Rulkov et al., 1995)
studies coupled identical systems to coupled systems with
different parameters, these investigations are expected
particularly useful in assessing coupled EEG signals.
Generalized synchronization occurs between two dynamical
systems X and Y (a driver and a response) when the state of
response system is a generalized function of the state of the
driver [i.e. YZJ (X); in Appendix A for more details].
This method might allow for relevant information on
possible similar features among EEG signals in different
cortical areas.
As such observations might contribute not only to
investigate cortical rhythms in relation to the epileptic
discharges, but also can improve some basic knowledge ofINPH 2003962—11/7/2005—09:44—BELLA—156284—XML MODEL 5 – pp. 1–11general VNS mechanism, we have now examined the effect
of VNS on the EEG frequency profile by comparing the
average of the power spectra recorded 1 year and 1 week
before VNS activation with that obtained, respectively,
1 month and 1 year after VNS therapeutic activation.
A group of epileptic subjects affected by partial seizures
and treated with AEDs only and another group of
non-epileptic patients served as control.ED
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2. Methods
2.1. Patient selection
The patients for the study were selected from 1420
individuals who attended the Epilepsy Diagnostic and
Treatment Centre of Cagliari (Italy). From 16 patients
affected by drug-resistant partial epilepsy who were recently
implanted with a VNS device, we selected eleven subjects
(six men, five women) ranging in age from 26 to 44 years
(mean, 33.5 years) affected by non-lesional epilepsy ruling
out five subjects affected by lesional epilepsy. Although the
number of the patients enrolled in the study was relatively
small, the group was homogeneous in that the age,
the treatment, and the general characteristics of the seizures
were similar for all individuals. The right hemisphere was
considered to be the most likely site of the epileptic focus in
seven subjects while the left side was primarily involved in
four patients on the basis of several EEG recordings and
reports from the patients themselves or from family
members who witnessed ictal events. We also obtained
ictal video-EEG recordings for nine patients. In addition, the
focal activity was confirmed by a 24 h Holter EEG
recording for the other patients.
Each of the patients had been monitored for several years
(mean, 5.2 years) by the outpatient service before the
decision to implant a VNS device was taken. The main
selection criteria for inclusion in the study were: a relative
stability of clinical features related to interictal EEG
activity, the resistance to classical first- and second-line
antiepileptic drugs (AEDs) assessed monthly for optimal
range, the normal findings of neurological and psychiatric
evaluations, and the lack of abnormalities of cerebral
structure as revealed by a recent MRI scan. The possibility
and priority of treatment with a VNS device were discussed
with the patients, family members, and the institutional
ethical ad hoc committee. Informed consent was obtained
from the patients and their relatives after the nature of the
procedure had been fully explained and approved by
institutional review.
The characteristics of the selected patients are
summarized in Table 1. The change in seizure frequency
was calculated as: [(number of seizures after VNS implant
per trimester)K(number of seizures before implant per
trimester)]/(number of seizures before implant per
trimester) (Labar et al., 1998). Epileptogenic activity was
TTable 1
Characteristics of epileptic patients and effect of VNS on seizure frequency
Patient Age
(years)
Sex Age at seizure
onset (years)
AEDs Estimated site
of focal IEDs
Pre-VNS seizure
frequency
(/trimester)
Post-VNS seizure
frequency
(/trimester)
VNS-induced
change in seizure
frequency
(% after 1 year)
1 44 F 14 CBZCPRI Right FT 164 27 (C83)
2 32 M 7 CBZCFELB Left F 139 37 (C75)
3 26 M 19 CBZCVA Right F 102 18 (C83)
4 28 M 18 CBZCLMT Right FT 120 75 (C37)
5 37 M 7 CBZCLMT Right FT 184 122 (C33)
6 29 F 8 CBZCLMT Left F 108 89 (C17)
7 33 M 17 CBZCVA Right FT 202 141 (C30)
8 34 F 3 CBZ Right F 228 198 (C13)
9 44 M 6 CBZCVA Right FT 196 212 (K0.8)
10 33 F 10 VACTOP Left TP 98 61 (C37)
11 29 M 7 CBZCLMT Left FT 122 85 (C30)
Pre-VNS seizure frequency is the mean of the value obtained in the trimester immediately before implantation of the VNS device and that obtained 1 year
previously. Post-VNS seizure frequency is the mean of the value obtained in the last trimester after 1 year from VNS implantation.VNS-induced change in
seizure frequency (% after 1 year) indicates the percentage of seizure decrease (negative number) or increase (positive number) after 1 year of vagus
stimulation. CBZ, carbamazepine; PRI, primidone; FELB, felbamate; VA, Valproic Acid; LMT, lamotrigine; TOP, topiramate. FT, fronto-temporal lobe; TP,
temporal-parietal lobe; F, frontal lobe.
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316defined by the number of interictal epileptiform discharges
(IEDs), including isolated spikes, spikes and slow waves,
spikes-waves, and polyspikes-waves during 40 min
recording interpreted by a neurophysiologist blinded of
the experimental design (MM). The approved protocol
included no changes in anticonvulsant treatment during the
trial, unless serious side effects were manifested.
In order to detect possible early modifications in power
spectra after VNS, we calculated the data obtained 1 month
after the implant and 2 months after surgery when VNS was
switched at therapeutic values. Moreover, given that the
studies reporting real therapeutic advantage for different
parameters of VNS are still limited and not systematic, no
further attempt to modify the general settings (e.g. shift to
‘rapid cycling’) has been done during the entire trial.UN
CO
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ECTable 2Characteristics of epileptic patients treated with AEDs onlyPatient Age
(years)
Sex Age at seizure
onset (years)
AEDs Estimate
of focal
1 35 F 24 CBZCVA Left T
2 39 M 18 CBZCLMT Right PT
3 46 M 28 CBZ Left FT
4 23 M 15 CBZ Right F
5 34 M 11 TOP Right PT
6 42 F 32 LMTCLEV Right FT
7 27 M 20 CBZ Left FT
8 33 F 26 CBZCLMT Right FP
9 31 M 14 CBZ Left F
10 28 F 17 VACLEV Left TP
Pre-AEDs adjustment seizure frequency is the mean of the value obtained in the t
obtained 1 year previously. Post-AEDs adjustment seizure frequency is the mean o
AEDs-induced change in seizure frequency (% after 1 year) indicates the percenta
PRI, primidone; LEV, levetiracetam; VA, valproic acid; LMT, lamotrigine; TOP, t
lobe; F, frontal lobe.
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related to an efficacious AEDs effect during 1 year period,
we examined a separate group of 10 epileptic subjects
affected by partial epilepsy (mean age, 34 years) who were
admitted to the Regional Centre Against Epileptic Disorders
for an adjustment of the treatment. Though these patients
differed from VNS group in that they showed a less severe
form of epilepsy, most of the drugs administered, either de
novo or adjusted for the optimal range, were similar to
VNS group (Tables 1 and 2). In particular, carbamazepine
(CBZ) which represents by far the most used AED, was
administered at doses between 1000 and 1600 mg/day,
Valproic Acid (VPA) was administered at daily doses
between 800 and 1500 mg following the indications
obtained from seric concentrations. Lamotrigine (LMT)d site
IEDs
Pre-AEDs
adjustment seizure
frequency
(/trimester)
Post-AEDs
adjustment seizure
frequency
(/trimester)
AEDs-adjustment
induced change in
seizure frequency
(% after 1 year)
15 4 (C73)
21 6 (C71)
16 2 (C87.5)
8 0 (C100)
6 2 (C66)
22 4 (C82)
11 3 (C73)
7 0 (C100)
14 6 (C57)
13 7 (C46)
rimester immediately before the adjustment of the AEDs treatment and that
f the value obtained in the last trimester after 1 year from AEDs adjustment
ge of seizure decrease after 1 year AEDs adjustment. CBZ, carbamazepine;
opiramate; T, temporal lobe FT, fronto-temporal lobe; TP, temporal-parietal
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TFig. 1. Procedure for calculation of intra- and interhemispheric
synchronization. The ipsilateral or contralateral synchronization index
was obtained by comparison of EEG data recorded by the test electrode (!)
with those recorded by electrodes positioned on the same or contralateral
side. The arrows indicate that the same procedure was applied for 19
electrode positions.
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administration in both epileptic groups varied from 200 to
400 mg. Less used drugs were Topiramate (TOP), utilized at
250 mg a day, primidone (PRI) administered at 200 mg a
day, levetiracetam (LEV) used at 3000 mg a day and
felbamate given at 2400 mg a day.
2.2. Implantation of the VNS device
A vagus nerve stimulator (model 100 NCP Pulse
Generator; Cyberonics, Houston, TX), comprising a pulse
generator programmable by telemetry, was implanted in the
upper left side of the chest of each subject by a
neurosurgeon. A lead terminating in a double-coiled
electrode was positioned on the cervical portion of the left
vagus nerve. The stimulator was tested before implantation
by serial connection to an IBM-compatible laptop computer.
The position of the stimulator was checked after surgery by
a routine chest X-ray. The device was switched on at an
initial current of 0.25 mA after 1 week. The current was
increased by 0.25 mA each week until the value of 2 mA
was achieved. Stimulation of patients 2 and 9 was
subsequently reduced to 1.75 mA because of a painful
sensation that developed in the throat region after delivery
of a current of 2 mA. The other parameters conformed to the
‘high stimulation’ criteria (Binnie, 2000); the stimulation
cycle was 30 s on followed by 5 min off, the pulse duration
was 500 ms, and the signal frequency was 30 Hz. Once set,
these parameters were maintained throughout the duration
of the study.
2.3. EEG analysis
EEG data were recorded from the scalp with a 19
non-polarizable Ag–AgCl electrode-cap using the BQS 98
System Micromed (Mogliano, Veneto, Italy). The
impedance was !5 kU, sampling frequency 256 Hz, 16
bit resolution. All electrophysiological signals were
transduced by BQS98 System Micromed alternating current
(A/C) amplifiers and an amplifier sensitivity of 5 was used
for EEG (50 mV, 0.5 s duration calibration) corresponding
to a gain of 50,000 with half-amp low and high bandpass
filters set at 0.03 and 70 Hz, respectively. Monopolar left
and right electroculograms (EOG) and bipolar chin-check
electromyograms (EMG) were also recorded in order to
detect possible sleepiness and the 10/20-systems was used
(1986). The reference electrode was placed on the nose and
the ground electrode on the forehead.. The signals were
stored on the hard disk for off-line analysis. Five samples
corresponding to 75 s per trial were randomly selected for
each patient from a 40 min EEG recording. These samples
were screened for eye blinks, horizontal–vertical eye
movements, muscle artefacts and possible sleepiness by
visual inspection and were analyzed by averaging the
results obtained in each trial. The EEG signals were
filtered with elliptical filter banks to obtain the optimal
resolution of broadband parameters for delta (0.5–3 Hz),INPH 2003962—11/7/2005—09:44—BELLA—156284—XML MODEL 5 – pp. 1–11ED
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theta (4–7.5 Hz), alpha (8–12 Hz), beta (13–20 Hz), and
gamma (20–50 Hz) frequencies. Given that synchronization
analysis requires a zero-phase filtering distortion, we
performed a further procedure of forward–backward
filtering (Gustafsson, 1996).
Given that the EEG records are based on the 10/20
system with 19 electrodes, the power spectrum was
analyzed at each electrode location for each of the 5
frequency bands selected for the experimental design. The
mean of the squared Fourier amplitude coefficients was
determined. Coherence, defined as the cross spectral density
function normalized by individual auto-spectral density
functions (Nunez et al., 1997) and a robust nonlinear
interdependence estimator (N) were calculated in order to
assess the generalized synchronization among all channels
(Quian Quiroga et al., 2000).
For calculation of /N/, a reconstruction of state spaces of
each signal was performed with an embedding dimension
(/m/) related to the frequency band to be studied. We used
the method of Liangyue (Liangyue, 1997) to find the
minimum embedded dimension for each frequency band
and we set mZ10 for lower bands (delta, theta and alpha)
and mZ6 for beta and gamma band. A time lag (t) of 2 was
chosen in order to measure frequencies of!128 Hz.
The number of nearest neighbours (k) was set to 10 and a
Theiler correction for temporal correlation (w) was set to 20.
These settings have been used in order to increase the
sensitivity for possible underlying synchronization
according to non-linearity studies applied to EEG signals
(Quian Quiroga et al., 2002).
Both power spectrum and synchronization data were
calculated for non-overlapping epochs (1 s at 256 samples).
To reduce the amount of data, we considered short- and
long-range synchronization according to the location of the
electrodes in the same hemisphere or in the contra lateral
areas (Fig. 1). The data obtained were spatially arranged
following the EEG montage. To characterize regional
differences, we defined five region-based groups of
electrode-pair combinations and the absolute band power
FFig. 2. Regions of interest for synchronization analysis. L1: left Fp1-F7, F7-T3, T3-T5, T5-O1. L2: left Fp1-F3, F3-C3, C3-P3, P3-O1. C: central Fz-Cz, Cz-Pz,Pz-Oz. R1: right Fp2-F8, F8-T4, T4-T6, T6-O2. R2: right Fp2-F4, F4-C4, C4-P4, P4-O2.
F. Marrosu et al. / Clinical Neurophysiology xx (xxxx) 1–11 5
DTD 5 ARTICLE IN PRESS
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531for each band of these combinations was used as the
dependent vector for comparisons (Fig. 2). The power
spectra obtained after 1 year of VNS stimulation were
compared with the average of those obtained 1 year and
1 week before implantation of the VNS device.T
Fig. 3. power spectra of gamma bands in the regions of interest for epileptic
patients before and after VNS. Power spectrum (mV2/sGSD) are reported in
the x axis, the regions assessed L1, L2, C, R1 and R2 are reported in the y
axis. Statistical significance: *P!0.05, **P!0.01, ***P!0.001.
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2.4. Data analysis
Analysis of variance (ANOVA) for repeated measures
with the Huynh–Feldt correction where appropriate and
the post hoc Bonferroni–Duhn test were used for
comparisons of power spectra and synchronization within
and between groups. Because of spatial correlation
between the 5 zones, /P/ values have been corrected
for multiple testing with false discovery rate (FDR)
method (Benjamini and Hochberg, 1995) instead of using
the too conservative Bonferroni correction, which is
better suitable for assessing global variations. Alpha level
was set to 0.05. A normal distribution of power
spectra and of N was indicated by application of
Lilliefors modified Kolmogorov–Smirnov test (Dallal
and Wilkinson, 1986). Coherence data were subjected
to Fisher’s transformation, yielding z-coherences with an
approximately normal distribution. All calculations were
performed with The Matlab toolboxes (The Mathworks,
Natick, MA, USA).
The relation between the modification of percentage
changes in seizure frequency and in power spectra and
synchronization distribution was assessed from a bivariate
scattergram plot and Fisher’s R to Z two-tailed test
(StatView Software, Abacus Concepts, Berkeley, CA,
USA). A P value of !0.05 was considered statistically
significant.CLINPH 2003962—11/7/2005—09:44—BELLA—156284—XML MODEL 5 – pp. 1–11ED
 PR
OO3. ResultsComparison of the power spectrum of each frequencyband in the regions of interest for the EEGs recorded 1 year
and 1 week, respectively, before implantation of the VNS
device as well as 1 month after VNS activation at values of
1.25 mA, revealed neither quantitative nor qualitative
differences (not shown). Furthermore, whereas the power
spectra for the delta, theta, alpha, and beta frequency bands
were not significantly affected by VNS in the epileptic
patients, that for the gamma band was increased in both
hemispheres after VNS, with this effect being more
pronounced in the right hemisphere (Fig. 3). In contrast,
after 1 year the epileptic control group failed to show
modifications in the power spectra profile of all bands
though a small increase in gamma power spectrum at R1
and R2 was observed (Table 3).
T
 PR
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F
Table 3
Power spectra of frequency bands in the regions of interest for epileptic patients before and after VNS and for control subjects before and after AEDs change
Band Region EP AEDs only Pre EP AEDs only Post Epileptic patients
pre-VNS
Epileptic patients
post-VNS
Delta L1 73.0G11.9 87.9G5.0 90.0G10.6 84.0G7.2
L2 75.7G11.4 66.0G8.9 86.0G14.8 76.1G8.8
C 43.6G7.7 38.9G3.4 49.0G8.2 33.4G3.7
R2 81.9G5.7 72.2G14.4 80.0G7.2 94.2G13.3
R1 91.0G11.3 80.8G13.6 96.0G10.1 123.1G15.1
Theta L1 54.2G12.5 52.5G11.8 101.0G19.6 72.0G10.9
L2 56.8G12.2 50.8G11.9 90.0G13.8 81.7G11.9
C 46.9G11.0 36.9G10.9 79.0G14.8 50.4G7.4
R2 61.7G12.0 53.6G12.6 100.8G16.7 89.3G10.9
R1 67.9G11.7 64.3G12.3 107.0G17.2 82.4G11.9
Alpha L1 70.0G13.3 44.7G10.1 67.0G13.5 43.8G9.0
L2 61.4G12.0 61.7G9.3 59.0G11.7 52.7G11.1
C 38.6G6.6 34.6G9.0 32.0G8.5 31.5G8.0
R2 58.4G12.7 59.9G9.8 58.0G11.9 44.5G10.6
R1 56.1G13.0 44.8G12.8 61.0G11.4 41.7G9.5
Beta L1 17.6G3.1 18.9G2.8 21.0G3.7 22.1G3.2
L2 16.9G5.6 12.8G2.6 17.0G3.7 21.0G2.9
C 11.3G2.8 19.7G3.3 13.0G3.2 12.1G1.9
R2 18.5G5.2 20.0G4.6 17.0G4.0 20.0G2.7
R1 18.6G4.5 18.9G3.5 19.0G3.2 24.0G3.2
Gamma L1 9.7G4.0 11.5G3.6 17.0G3.4 21.9G4.0a
L2 6.5G2.0 7.9G2.8 8.9G1.9 13.0G2.9b
C 4.6G1.1 5.0G1.3 5.0G1.1 4.9G1.1
R2 7.3G1.4 7.9G2.4 5.9G1.1 13.1G1.9c
R1 10.7G3.0 12.2G3.4 11.0G2.3 27.0G3.7c
EP-AEDs Pre and EP-AEDs-Post, power spectra values in the control group treated with AEDs only (basal values) and the same group assessed 1 year after
AEDs switch. Values are calculated as mean between basal (EP-AEDs-Pre) and after 1 year from the switch (AEDs-Post). EP Pre-VNS values for epileptic
patients as mean average of the power spectra determination 1 year and 1 week before VNS implant. EP Post-VNS spectra values obtained after 1 year from the
switch ofO1.25 mA (following therapeutic values of VNS). Values expressed as mV2/sGSD values are assessed with analysis of variance (ANOVA): a, P!0.
05; b, P! 0.01; c, P!0.001.
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Moreover, after 1 year of VNS activation, in addition to
the general increase in gamma power spectrum,
VNS-treated group showed an increased coherence for
gamma signals at the R1 region of the right hemisphere,
confirmed by statistical analysis based on the interdepen-
dence factor N (Table 4). Although VNS failed to decrease
theta power spectrum (Table 2), this group showed a
significant reduction in the inter- and intrahemisphericUN
CO
RR
E
Table 4
Effects of VNS on intra- and interhemispheric synchronization of EEG activity f
Region Coherence
Band VNS-induced
change (%)
P
L1
L2 Inter
Intra
C Inter Theta K4.4 0
Intra Theta K6.2 0
R2 Inter
R1 Inter
Intra Gamma 4.9 0
The change in coherence or interdependence (N) obtained 1 year after VNS switch
week before surgery P!0.05 respect baseline.
INPH 2003962—11/7/2005—09:44—BELLA—156284—XML MODEL 5 – pp. 1–11EDcoherence for this band in the central (C) region (Table 4).Again, the VNS-induced decrease in synchronization for thetheta band in the C region was confirmed by analysis of N.
In the AEDs group the synchronization analysis showed
a decrease in both coherences and N after 1 year for delta,
theta and gamma bands (Table 5). The correlation between
the percentage changes in seizure frequency pattern
distribution and the power spectra and synchronizationor the regions of interest
Interdependence measure (N)
Band VNS-induced
change (%)
P
Beta K1.3 0.027
.041 Theta K4.8 0.021
Beta K2.1 0.035
.026 Theta K5.3 0.013
Beta K2.2 0.043
Beta K1.6 0.037
Gamma 3.2 0.039
.028 Gamma 4.3 0.01
(O1.25 mA) is compared with mean baseline values between 1 year and 1
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Table 5
AEDs-group: effects of AEDs on intra- and interhemispheric synchronization of EEG activity for the regions of interest of epileptic controls
Region Coherence Interdependence measure (N)
Band AEDs-induced
change (%)
P Band AEDs-induced
change (%)
P
L1 Inter Gamma K0.29 0.043 Gamma K0.54 0.018
Intra
L2 Inter
Intra Delta K1.1 0.042
Theta K0.9 0.034
C
R2 Inter
Intra Delta K1.4 0.031 Delta K1.3 0.028
R1
The change in coherence or interdependence (N) obtained 1 year after AEDs change is compared with the basal valuesP!0.05 respect basal values.
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750distribution was not significant in both groups, thus
suggesting that the improvement in seizure frequency was
not proportionally related with these parameters (not
shown). No variations were observed in spectra profiles
and coherence in the group of non-epileptic subjects after 1
year (Table 2). Furthermore, the number of IEDs was not
significantly modified by VNS.T
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4. Discussion
We have shown that VNS increases the power spectrum
as well as the intra- and interhemispheric synchronization of
EEG frequencies between 20 and 50 Hz (gamma band)
(Fig. 3), whereas it reduces the synchronization of
frequencies under 20 Hz without substantially affecting
their power spectra. At variance, the control group showed
similar power spectra after 1 year of AEDs adjustment
(Table 3).
Though VNS failed to show acute modifications
following on and off periods of activation (Salinski and
Burchiel, 1993), experimental evidences have suggested
that electrical stimulation induced modification of brain
rhythms via the nucleus tractus solitarius (NTS), which is
the main site of visceral afferent complex termination and is
regulated by cholinergic inputs (Beckstead and Norgren,
1979; Kalia and Sullivan, 1982; Rutecki, 1990; Schacther
and Saper, 1998). However, the extended network of NTS
connections (Saper, 1995) might mediate the biochemical
and electrical effects of VNS through several mechanisms.
Given that the NTS does not directly innervate cortical
areas, chronic VNS-induced EEG changes are likely
mediated by modulation of pathways indirectly involved
in the genesis of cortical rhythms. Indeed, the parabrachial
nucleus, which receives NTS efferents (Quattrocchi et al.,
1998) projects to several thalamic nuclei that contribute to
EEG activity and receives an important input from the locus
coeruleus (LC). In addition, the integrity of the LC is
important for the antiepileptic, desynchronizing, and
arousal-promoting effects of VNS (Krahl et al., 1998).CLINPH 2003962—11/7/2005—09:44—BELLA—156284—XML MODEL 5 – pp. 1–11ED
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Moreover, experimental stimulation of vagal components of
the LC by injection of the cholinergic agonist bethanechol
into the LC was found to increase cortical desynchroniza-
tion and to reduce the contribution of slow frequencies to
the EEG (Berridge and Foote, 1991). Although such studies
cannot be readily replicated in humans, in addition to its
antiepileptic effect VNS affects EEG desynchronization
through the entire sleep-waking cycle by increasing the
proportion of rapid eye movements (REM) sleep and
decreasing daytime sleepiness (Galli et al., 2003; Malow
et al., 2001). Our present results confirm that chronic VNS
increases intra-interhemispheric desynchronization of cor-
tical rhythms at frequencies of!20 Hz. These results are in
accordance with previous experimental and clinical data. It
has been shown, for instance, that VNS suppress sleep
spindling in cats whereas it attenuates synchronized
activities (Chase et al., 1967l; Zanchetti et al., 1952).
Though in initial investigations EEG background seemed
unaffected by VNS (Hammond et al., 1992; Salinski and
Burchiel, 1993) in more recent studies it has been suggested
a ‘cortical activation among the effects of VNS’ as it
promotes REM sleep and increases alertness without any
change in overnight sleep architecture (Malow et al., 2001).
The VNS-induced desynchronization described in cats
after VNS, (Magnes et al., 1961), represents a finding which
apparently seems to contradict the increased synchroniza-
tion of gamma frequency bands in humans. However, it is
difficult to compare these experimental settings given the
methodological differences in stimulus parameters and in
species population and the different acquisition and
processing of EEG signals. Together, the existence of a
single mechanism responsible both for the decreased
synchronization of frequency bands under 20 Hz and for
the marked increase in the power spectrum and
synchronization of the gamma frequency band appears
difficult to council.
Gamma activity has previously been found to be
increased in experimental models of epilepsy and in
epileptic patients (Mackenzie et al., 2002; Willoughby
et al., 2003). Consistent with these findings, the epileptic
TCL
F. Marrosu et al. / Clinical Neurophysiology xx (xxxx) 1–118
DTD 5 ARTICLE IN PRESS
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896UN
CO
RR
EC
patients in the present study showed an increased power
spectrum of the gamma frequency band compared with that
observed in non-epileptic subjects. Moreover, the VNS
group manifested a further increase in this parameter after 1
year of stimulation.
It has been shown that a reduction in synchronization of
the gamma band has been detected immediately before an
epileptic seizure (Mormann et al., 2003). In addition,
experimental data suggest that an antisynchronizing
gamma-mediated mechanism may antagonize ictal and
interictal epileptogenic spiking activity (Medvedev, 2002)
as these figures are proportionally inverse. Accordingly, the
increases in the power spectrum of the gamma band
observed in response to VNS in the present study might
be hypothesized as a kind of protective effect. The
performance of standard EEG, recorded for only 40 min in
the present study,was not optimally suited to detect
significant variations in spiking activity. However, previous
studies with longer periods of EEG monitoring have shown
that long-term VNS induces a delay in interspiking activity
and a reduction in the frequency of epileptic interictal spikes
(Koo, 2001; Kuba et al., 2002; Olejniczak et al., 2001),
though a recent study which evaluated in children whether
spike rates are useful as an outcome parameter following
VNS yielded contrasting results (Ebus et al., 2004).
Chronic VNS has been found to enhance recognition
memory and memory storage in humans (Clark et al., 1999)
and to increase cortical inhibition by up-regulating the
cortical density of g-aminobutyric acid type A (GABAA)
receptors, as assessed by [123I] iomazenil SPECT, in
individuals with drug-resistant partial epilepsy (Marrosu
et al., 2003). These results suggest that VNS may modulate
neuronal plasticity. Moreover, given that modifications of
GABAA receptors affect brain excitability, it seems likely
that this receptor modulation might also be involved in
changes of bioelectrical activity.
Recent studies have suggested that local gamma rhythms
are dependent on the activation of GABAA receptors in
perisomatic neural networks whose synaptic inputs
synchronize the interneuronal activity in the gamma range
(Jefferys et al., 1996; Traub et al., 2003). Though these
studies are performed on neuronal models represented by
hippocampal slices, the possibility that the GABAergic
inhibition in a subset of interneurons into pyramidal cells
modulates gamma activity (Wendling et al., 2002) can be
hypothesized also in other brain areas that share high
density GABAA receptors. Given that VNS increases the
metabolic rate in the thalamus (Henry et al., 1998, 1999,
2004; Ko et al., 1996) the long-term administration of such
stimulation might affect thalamocortical regulation of brain
circuitry involved in the modulation of EEG rhythms. It is
likely that this effect is part of the antiepileptic mechanism,
and that it is induced after a medium-long delay from VNS
activation, since both clinical activity and power spectrum
assessed 1 month after settling the device at 1.25 mA failedINPH 2003962—11/7/2005—09:44—BELLA—156284—XML MODEL 5 – pp. 1–11ED
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to show significant differences in comparison with these
calculated for the pre-implant periods (not shown).
The modulation of the GABAA receptors by VNS might
be relevant for the regulation of cortical rhythms, given that
the nucleus reticularis thalami contains a large proportion
of GABAAergic neurons and acts as a pacemaker of
thalamocortical volleys (Gibbs et al., 1996). Though VNS
activates both thalami and this mechanism represents the
most likely candidate to the regulation of oscillatory brain
activities, our data show an asymmetric prevalence of
gamma bands over the right hemisphere, regardless the
putative epileptogenic side. Although the lateralized gamma
power spectrum can be interpreted as a casual finding,
nonetheless the peculiar pattern of gamma profiles detected
in the VNS group might suggest a more direct mechanism.
Indeed, it has been observed that VNS induces bilateral
thalamo-cortical blood flow increase both acutely and
chronically (Henry et al., 1998, 1999; Ko et al., 1996),
and that the left position of VNS implant enhances an
additional chronic increase in the right inferior postcentral
gyrus (Henry et al., 2004). Though it is difficult to directly
correlate minute variations in blood flow with EEG changes,
the chronic blood flow asymmetry could play a role in
modifying synaptic plasticity in these areas. However, the
role of the AEDs in determining the EEG changes deserves
some comment. Indeed, it cannot be completely ruled out that
the epileptic groups receiving the same AEDs may show
different power spectra for complex AEDs–VNS interactions
(e.g. VNS acts by enhancing AEDs–GABA related
mechanisms) rather than by a VNS ‘mechanistic’ effect,
though the group treated with AEDs only failed to show
significant changes in frequency profiles (Tables 3 and 5).
In addition, several studies reported a time-dependent
improvement of the quality of life and mood among the
patients treated with VNS (Ben-Menachem, 2002; Cramer,
2001; Elger et al., 2000; Harden et al., 2000 for a review)
and recent investigations have suggested a potential effect
of VNS in the treatment of depression (Kosel and
Schlaepfer, 2003). Given that the modulation of gamma
bands plays a role in linking different brain areas involved in
object representation as well as in unifying coherent
percepts and in focusing the top-down flow of attentional
mechanisms (Bertrand and Tallon-Baudry, 2000) it could be
suggested that, perhaps independently by the antiepileptic
mechanism, these effects might contribute to the
improvement of the quality of life in epileptic subjects as
well as in depressed patients.
Though it is not currently possible to hypothesize the
exact role played by the modifications of the frequency
power spectrum and synchronization in VNS antiepileptic
effects and the small sample of the patients selected for the
present report does not allow for sufficient statistical
analysis, these preliminary results suggest that a time-
dependent VNS-mediated mechanism can modulate the
expression of several brain rhythms possibly involved
in more than the seizure control. Larger prospective
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Appendix A
Embedded synchronization in EEG signals is performed
by adapting the non-linear synchronization measure intro-
duced by Quian Quiroga et al. (2002) from the work of
Arnhold et al. (1999). Unlike coherence, cross-correlation
and mutual information, this measure is non-symmetric and
yields more detailed information about the ‘direction’ of
interdependence. Briefly, in order to detect generalized
synchronization we synthesize the general principles.
Let xZ(x1,.,xN) and yZ(y1,.,yN) two different
simultaneously observed EEG time sequences opportunely
sampled related to dynamical systems X and Y.
Time-delay embedding in a m-dimensional phase-space
leads to vectors xnZ ðxn;.; xnKðmK1ÞtÞ and ynZ ðyn;.;
ynKðmK1ÞtÞ where t indicates the time delay.
Let rn,j and Sn,j, jZ1,.,k the time indices of the k nearest
neighbours of xn and yn, respectively. Thus, the first neighbour
distances fromxnaredðXÞð1Þn hjjxnKxrn;1 jjZminqjjxnKxqjj,
dðXÞð2Þn hjjxnKxrn;2 jjZminqsrn;1 jjxnKxqjj, etc., wherekxKx 0k is the ‘Euclidean distance’ in delay space. For
each xn and yn, the squared mean Euclidean distance to its k
closest neighbours is defined as
RðkÞn ðXÞZ 1
k
Xk
jZ1
jjxnKxrn;j jj (1)
and the conditional mean square Euclidean distance,
conditioned on the closest neighbour times in the time series
Y, is
RðkÞn ðXjYÞZ 1
k
Xk
jZ1
jjxnKxsn;j jj (2)
Note that in (2), instead of summing over nearest
neighbours as in (1), we sum over points whose equal time
partners are nearest neighbours of yn. The same can be done
symmetrically for yn obtaining
RðkÞn ðYÞZ 1
k
Xk
jZ1
jjynKysn;j jj (3)CLINPH 2003962—11/7/2005—09:44—BELLA—156284—XML MODEL 5 – pp. 1–11ED
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and
RðkÞn ðYjXÞZ 1
k
Xk
jZ1
jjynKyrn;j jj: (4)
Introducing the average distance between the reference
vector and all other vectors in the data set {Xn}
RðNK1Þn ðXÞhRnðXÞZ 1
NK1
XNK1
mZ1
kxnKxmk; (5)
we can observe that, ifX andY are strongly coupled we have
RðkÞn ðXjYÞzRðkÞn ðXÞ/RnðXÞ while if they are independent
RðkÞn ðXjYÞzRnðXÞ[RðkÞn ðXÞ.
Thus, we define local and global interdependence
measure, respectively as
NðkÞn ðXjYÞZ RnðXÞKR
ðkÞ
n ðXjYÞ
RnðXÞ (6)
and
NðkÞðXjYÞh 1
N
XN
nZ1
NðkÞn ðXjYÞ
Z
1
N
XN
nZ1
RnðXÞKRðkÞn ðXjYÞ
RnðXÞ (7)
This measure is normalized in the sense that
N(k)(XjY)Z0 in case of uncorrelated signal and N(k)(XjY)
z1 in the case of perfect coupling (in general RðkÞn ðXjYÞ will
not go exactly to zero so this measure will not reach 1 even
in case of perfect synchronization).
We used this interdependence measure to compare
non-overlapping epochs for each couple of channels.
Results have been averaged on regions reported in Fig. 1.References
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